Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-11-04 11:17 am Purchase | 13G | CYTOKINETICS INC CYTK | VANGUARD GROUP INC | 11,761,605 9.990% | 744,716 (+6.76%) | View |
2024-10-23 5:04 pm Purchase | 13G | CYTOKINETICS INC CYTK | 15,252,905 13.000% | 15,252,905 (New Position) | View | |
2024-02-13 5:02 pm Purchase | 13G | CYTOKINETICS INC CYTK | VANGUARD GROUP INC | 11,016,889 11.240% | 943,795 (+9.37%) | View |
2024-02-09 08:50 am Sale | 13G | CYTOKINETICS INC CYTK | FMR LLC | 13,007,783 13.265% | -401,460 (-2.99%) | View |
2024-02-08 10:11 am Sale | 13G | CYTOKINETICS INC CYTK | WELLINGTON MANAGEMENT GROUP LLP | 6,530,884 6.660% | -11,840 (-0.18%) | View |
2024-01-25 10:45 am Purchase | 13G | CYTOKINETICS INC CYTK | STATE STREET CORP STT | 5,893,358 6.010% | 848,444 (+16.82%) | View |
2024-01-22 2:03 pm Purchase | 13G | CYTOKINETICS INC CYTK | BlackRock Inc. BLK | 16,300,541 16.400% | 532,667 (+3.38%) | View |
2023-02-10 2:11 pm Unchanged | 13G | CYTOKINETICS INC CYTK | BlackRock Inc. BLK | 15,767,874 16.700% | 0 (Unchanged) | View |
2023-02-09 11:16 am Purchase | 13G | CYTOKINETICS INC CYTK | VANGUARD GROUP INC | 10,073,094 10.640% | 1,331,970 (+15.24%) | View |
2023-02-09 09:59 am Purchase | 13G | CYTOKINETICS INC CYTK | FMR LLC | 13,409,243 14.162% | 819,408 (+6.51%) | View |
2023-02-06 2:51 pm Purchase | 13G | CYTOKINETICS INC CYTK | WELLINGTON MANAGEMENT GROUP LLP | 6,542,724 6.910% | 6,542,724 (New Position) | View |
2023-02-03 09:51 am Purchase | 13G | CYTOKINETICS INC CYTK | STATE STREET CORP STT | 5,044,914 5.330% | 1,059,687 (+26.59%) | View |
2023-01-26 08:52 am Purchase | 13G | CYTOKINETICS INC CYTK | BlackRock Inc. BLK | 15,767,874 16.000% | 800,557 (+5.35%) | View |
2023-01-20 3:00 pm Purchase | 13G | CYTOKINETICS INC CYTK | BlackRock Inc. BLK | 14,967,317 16.000% | 2,016,353 (+15.57%) | View |
2022-04-08 4:31 pm Purchase | 13G | CYTOKINETICS INC CYTK | VANGUARD GROUP INC | 8,741,124 10.300% | 1,751,405 (+25.06%) | View |
2022-02-14 09:42 am Sale | 13G | CYTOKINETICS INC CYTK | Driehaus Capital Management LLC | 2,327,112 2.770% | -712,144 (-23.43%) | View |
2022-02-09 3:43 pm Purchase | 13G | CYTOKINETICS INC CYTK | VANGUARD GROUP INC | 6,989,719 8.330% | 2,167,729 (+44.96%) | View |
2022-02-09 12:49 pm Sale | 13G | CYTOKINETICS INC CYTK | STATE STREET CORP STT | 3,985,227 4.750% | -655,696 (-14.13%) | View |
2022-02-09 09:11 am Purchase | 13G | CYTOKINETICS INC CYTK | FMR LLC | 12,589,835 14.999% | 4,101,153 (+48.31%) | View |
2022-01-27 1:59 pm Unchanged | 13G | CYTOKINETICS INC CYTK | BlackRock Inc. BLK | 12,950,964 15.400% | 0 (Unchanged) | View |